Newsletter

Pol. Merkur. Lek (Pol. Med. J.), 2016, XL/235: 036-039 Maximize

Pol. Merkur. Lek (Pol. Med. J.), 2016, XL/235: 036-039

Title: Diagnostic imaging methods of cardiac dysfunction caused by cardiotoxicity of oncological therapy

Authors: Lelakowska-Pieła M, Słowik A, Kozynacka A, Panek M, Konduracka E, Nessler J.

More details

08/235

40,00 zł

SUMMARY IN POLISH & ENGLISH. FULL ARTICLE ONLY IN POLISH.

Diagnostic imaging methods of cardiac dysfunction caused by cardiotoxicity of oncological therapy


Lelakowska-Pieła M1, Słowik A2, Kozynacka A1, Panek M1, Konduracka E1, Nessler J1.

1Department of Coronary Disease and Heart Failure, Institute of Cardiology, Jagiellonian University, Medical College, John Paul II Hospital, Cracow, Poland; 2Oncology Department, Jagiellonian University, Medical College, Cracow, Poland Cardiotoxicity of chemotherapy is a serious complication of oncological treatment. Assessment of cardiac function before, during and after cardiotoxic chemotherapy course should be a standard procedure in oncology. There are several methods for evaluation of the changes in myocardium such as: electrocardiography, radiology techniques (RTG, CT, MRI, PET-CT, PET-MRI), echocardiography, radioisotope imaging techniques (scyntygraphy, MUGA, PET), and ultra-structure evaluation in biopsy samples. Nevertheless, there is a continuous need for new diagnostic methods of cardiac dysfunction of great predictive and prognostic importance. Unfortunately advanced imaging techniques are still not available in many oncological centers in Poland. Nowadays to evaluate potential cardiotoxicity of drugs in oncology it is postulated to perform serial echocardiographic examinations as a basal imaging method. Thus constant cooperation between cardiologist and oncologist plays crucial role during chemotherapy.

Key words: cardiotoxicity, chemotherapy cardiac dysfunction.

Pol Med J, 2016; XL (235); 36–39